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Letter to the Editors ajog.orgPotential challenges in managing obstetrical
patients with coronavirus disease 2019TO THE EDITORS: We read with great interest the article by
Yan et al.1 The authors must be congratulated for their robust
analysis of 116 obstetrical patients with coronavirus disease
2019 (COVID-19), in which no maternal deaths and a low
rate of spontaneous preterm birth were reported.
Although they are reassuring, we must not take for granted
the largely optimal outcomes reported. Being the largest series
of pregnant patients with COVID-19 to date, the authors
present the most comprehensive analysis we have witnessed
so far on this distinct group of patients. However, their
findings must be interpreted with the caveats they have
highlighted. Only slightly over half of the included patients
had laboratory-diagnosed COVID-19, among which there
was a substantially higher rate of preterm delivery before 37
weeks’ gestation (32.0% vs 10.2% in clinically diagnosed
patients). Furthermore, although no association was identi-
fied between COVID-19 and risk of spontaneous preterm
birth, the authors found an increased risk of any preterm
birth before 37 weeks’ gestation. This was despite the fact that
among the 18 cases that had presented before 34 weeks’
gestation, 14 were still ongoing at the point of study
completion.
It is recognized that physiological maternal adaptations to
pregnancy predispose pregnant patients to a more severe case
of pneumonia and hence to higher maternal-fetal morbidity
and mortality, especially owing to their inadvertent immu-
nosuppressed state. Increased complication rates have been
reported in pregnant patients with swine flu (H1N1) and
severe acute respiratory syndrome coronavirus (SARS-CoV)
infection.2 At present, little is known regarding the interplay
between COVID-19 and pregnancy, but there is a possibility
of COVID-19 following a similar clinical course as SARS-CoV
and even H1N1.
In general, peripartum women are susceptible to disease
progression to acute respiratory disease syndrome. Mechan-
ical ventilation in pregnant patients can be technically chal-
lenging because of the difficulty with prone positioning.
Extracorporeal membrane oxygenation (ECMO) has been
shown to have favorable maternal and fetal survival rates in
peripartum patients and should be considered early as a
salvage therapy.3 Another potentially challenging complica-
tion is acute kidney injury (AKI). Outcomes of continuous
renal replacement therapy for AKI in pregnancy are poor.
Furthermore, renal complications for pregnant patients onECMO have been shown to be a risk factor for poor survival
outcome.4
Nonetheless, on a more optimistic note, Yan et al1 have
managed an impressive feat in their analysis of the 116
obstetrical patients with COVID-19. The current study has
laid the groundwork for future research to build upon and
address the questions that remain on this topic. -
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